Challenges with tracing patients on antiretroviral therapy who are late for clinic appointments in rural South Africa and recommendations for future practice. by Etoori, David et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=zgha20
Global Health Action
ISSN: (Print) (Online) Journal homepage: https://www.tandfonline.com/loi/zgha20
Challenges with tracing patients on antiretroviral
therapy who are late for clinic appointments
in rural South Africa and recommendations for
future practice
David Etoori , Alison Wringe , Jenny Renju , Chodziwadziwa Whiteson
Kabudula , Francesc Xavier Gomez-Olive & Georges Reniers
To cite this article: David Etoori , Alison Wringe , Jenny Renju , Chodziwadziwa Whiteson
Kabudula , Francesc Xavier Gomez-Olive & Georges Reniers (2020) Challenges with
tracing patients on antiretroviral therapy who are late for clinic appointments in rural South
Africa and recommendations for future practice, Global Health Action, 13:1, 1755115, DOI:
10.1080/16549716.2020.1755115
To link to this article:  https://doi.org/10.1080/16549716.2020.1755115
© 2020 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
Published online: 28 Apr 2020.
Submit your article to this journal Article views: 1619
View related articles View Crossmark data
ORIGINAL ARTICLE
Challenges with tracing patients on antiretroviral therapy who are late for
clinic appointments in rural South Africa and recommendations for future
practice
David Etoori a, Alison Wringe a, Jenny Renjua,b, Chodziwadziwa Whiteson Kabudulac,
Francesc Xavier Gomez-Olivec and Georges Reniers a,c
aDepartment of Population Health, London School of Hygiene and Tropical Medicine, London, UK; bDepartment of Epidemiology and
Biostatistics, Kilimanjaro Christian Medical University College, Moshi, Tanzania; cMRC/WITS Rural Public Health and Health Transitions
Research Unit (Agincourt), School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
ABSTRACT
Background: It is common practice for HIV programmes to routinely trace patients who are
late for a scheduled clinic visit to ensure continued care engagement. In South Africa, patients
who are late for a scheduled visit are identified from clinic registers, and called by telephone
up to three times by designated clinic staff, with home visits conducted for those who are
unreachable by phone. It is important to understand outcomes among late patients in order
to have accurate mortality data, identify defaulters to attempt to re-engage them into care,
and have accurate estimates of patients still in care for planning purposes.
Objective: We conducted a study to assess whether tracing of HIV patients in clinics in rural
north-eastern South Africa was implemented in line with national policies.
Methods: Thirty-three person-day of observations took place during multiple visits to eight
facilities between October 2017 and January 2018 during which clinic tracing processes were
captured. The facility level implementation processes were compared to the intended tracing
process and gaps and challenges were identified.
Results: Challenges to implementing effective tracing procedures fell into three broad
categories: i) facility-level barriers, ii) issues relating to data, documentation and record-
keeping, and iii) challenges relating to the roles and responsibilities of the different actors
in the tracing cascade.
We recommend improving linkages between clinics, improving record-keeping systems,
and regular training of community health workers involved in tracing activities. Improved
links between clinics would reduce the chance of patients being lost between clinics. Record-
keeping systems could be improved through motivating health workers to take ownership of
their data and training them on the importance of complete data. Finally, training of
community health workers may improve sustained motivation, and improve their ability to
respond appropriately to their clients’ needs.
Conclusions: Substantial investment in data infrastructure and healthcare staff training is
needed to improve routine tracing.
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Background
At the end of 2017, it was estimated that 34.6 million
adults aged 15 years and older were infected with
HIV worldwide, 70% of whom resided in sub-
Saharan Africa [1]. New treatment guidelines calling
for immediate lifelong treatment for everybody test-
ing positive for HIV (known as “Test and Treat”)
resulted in 15.4 million individuals initiating antire-
troviral therapy (ART) by the end of 2017, represent-
ing 60% of all people living with HIV (PLHIV) in
sub-Saharan Africa [1]. By the end of 2015, South
Africa had the largest ART programme in the world
[2,3]. In 2016 South Africa adopted the ‘Test and
Treat’ policy which translated to even more people
being eligible for treatment [4,5]. By the end of 2018,
an estimated 68% of the 7.2 million PLHIV in South
Africa were on ART [1,6].
PLHIV who are taking lifelong ART who are late for
scheduled clinic appointments are labelled as lost to
follow-up (LTFU), a general term that amalgamates sev-
eral possible outcomes including death, default, and self-
transfer to another clinic [7–9]. Failure to account for the
true outcomes of patients deemed LTFU leads to asmuch
as five-fold underestimation of retention because silent
(undocumented) transfers are not taken into account
[10]. Similarly, default rates are over estimated as all
patients that are LTFU are assumed to have stopped
taking treatment [10,11]. Furthermore, if only deaths
reported to the clinic are included in mortality estimates
this results in thembeing underestimated. Inaccuracies in
calculating the actual number of people alive and onART
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has implications in the estimation of national ART cover-
age and corresponding ART programme budgets. Silent
transfers can lead to double counting of the number of
people who have ever initiated ART which could lead
to overestimates of ART supplies needed, and
over-estimates of ART programme coverage in national
evaluations which could result in a reduced focus on
reaching coverage targets [12]. Finally, misclassification
of patients who are alive and on ART elsewhere as LTFU
underestimates the impact of ART on mortality [11,13]
which is an important statistic for programme monitor-
ing as well as for informing HIV modelling and projec-
tions by UNAIDS [14–16].
Effective tracing programmes are likely to become
increasingly important in the context of ‘Test and
Treat’ strategy as more asymptomatic patients are
initiating ART and may have higher rates of LTFU
[17]. Tracing is effective at improving engagement
with studies showing that as many as 86% of patients
who had defaulted from care reengage in care follow-
ing tracing [8,18,19] and that active tracing signifi-
cantly reduces attrition [11,20]. Moreover, continued
retention is crucial to mitigate the risk of develop-
ment of resistance in patients who do not adhere
correctly to ART [21–24]
Previous studies have documented some challenges
related to tracing patients in HIV programmes in sub-
Saharan Africa including organisational challenges,
health worker shortages, and high costs which continue
to limit the ability of HIV programmes to trace patients
who are missing or LTFU [25,26], but few recommen-
dations are made to mitigate these challenges.
This paper describes the challenges that were
observed with routine tracing in the primary health
care system in north-eastern South Africa, comparing
policy to actual implementation. The observations
were made whilst undertaking a study to consolidate
routine tracing information and conduct supplemen-
tary tracing for PLHIV who were LTFU in
a decentralised HIV treatment programme in the
same setting. Recommendations to address these
challenges are made to improve the implementation
of tracing systems in this setting and beyond.
Methods
Setting
The clinics included in the broader tracing outcomes
study were those serving the population of the
Agincourt Health and Demographic Surveillance
System (HDSS). The HDSS study area covers
475 km2 in Bushbuckridge, Mpumalanga province,
north-eastern South Africa. Agincourt HDSS has
been tracking demographic and health events (i.e.
births, deaths and migration) in Tsonga or Shangaan
people since 1992 [27,28]. By 2014, the population was
approximately 115,000 people living in 17,000 house-
holds spread over 30 villages [28]. The study site is run
under the auspices of the Medical Research Council
(MRC)/Wits Rural Public Health and Health
Transitions research unit, administrated by the
School of Public Health at the University of
Witwatersrand (WITS). Agincourt HDSS population
is served by five primary health clinics and three sec-
ondary community health centres. Every HIV-positive
patient has a clinical file that is established when they
first register at the ART clinic and updated at each
clinic visit. Following the clinic visit, visit-level infor-
mation from the patient file is entered into the national
electronic database, TIER.Net. Since 2014, Agincourt
HDSS has undertaken an exercise called Point-of-
contact Interactive Record Linkage (PIRL) [29]
where chronic care patient visits in the clinics have
been recorded and linked to the patient’s HDSS
record, provided that they ever lived in the HDSS.
Study design
The challenges and recommendations presented in this
paper are based on 33 person days of observations in
eight primary healthcare facilities (Table 1) in the
Bushbuckridge sub-district between October 2017 and
January 2018. Clinics were chosen because they were
located within the HDSS. Each clinic was visited at least
three times over this period to ascertain tracing outcomes
for patients that were believed to be LTFU (more than
90 days late for a schedule clinic appointment). Briefly,
this mixed methods study involved a comprehensive
review of available clinic records documented through
TIER.Net (the national electronic HIV patient monitor-
ing database) and paper-based patient clinic files.We also
consulted logbooks from Right-to-Care (RtC) and
Home-Based Carers (HBC), two non-profit organisa-
tions that assist with tracing HIV patients LTFU through
telephone calls and household visits respectively (Box 1).
We then worked with these organisations to con-
duct a further home visit for all patients for whom
routine tracing had not previously been undertaken,
or for those without a definitive outcome after record
review. Observations of how the tracing systems
operated were captured in logbooks. Primary health-
care facility managers usually a sister-in-charge
(nurse) were informally consulted for further clarifi-
cation of how the implementation took place in prac-
tice. In cases where the sister-in-charge was
unavailable, RtC officers, clinic data typists or other
nurses were consulted. We also visited ten HBC
organisations to document how their work inter-
sected with that of the clinics’ tracing system.
Additionally we reviewed one national policy docu-
ment [30], which detailed how tracing should take
place and had further conversations with other sta-
keholders and key actors.
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Data collection
As part of the comprehensive clinic record review, we
collected data from TIER.Net and patient files for 1325
patients that met the LTFU criteria on 15 August 2017.
Data included information on the patient’s treatment
status (i.e. still in care, deceased, transferred out) and
whether they had received a tracing intervention (typi-
cally a comment in their record about telephone or
physical tracing). From RtC and HBC, we asked to
view their tracing logs and collected data on any tele-
phone or physical tracing interventions for each LTFU
patient and the outcome of this tracing. Data were
entered into a Microsoft access database. Discussions
with HBCs centred around how physical tracing was
performed in practice, and their interactions with clinic
staff and patients.
In each clinic, through discussions with the staff, we
identified the most knowledgeable person regarding
each step and where possible asked for an explanation
of how tracing typically occurred.We also asked to view
all data collection instruments used in the tracing pro-
cess including late patient lists and the tracing registers.
Data were entered into an Excel spreadsheet.
Definitions
Implementation of tracing was defined as being opti-
mal if lists of late patients, tracing registers, telephone
and physical tracing were used as intended in policy
and well documented with clinic staff able to produce
these instruments when requested. Tracing implemen-
tation was defined as ‘inconsistent’ if it did not align
with policy or was not well documented. In the case of
telephone and physical tracing inconsistency could also
mean that these steps were not well documented, but
we found evidence of telephone and physical tracing in
patient files or TIER.Net. Tracing implementation was
classified as ‘not observed’ where clinic staff could not











Public 975 Yes Ward Based Outreach Team (WBOT)
nurse, Facility manager (Sister-in-
charge), Home Based Carers, Right-
to-Care linkage officer, community
health worker
6
Belfast clinic Public 582 Yes (started July 2017) Data typist, Right-to-Care linkage







a public facility, in
2016)
689 Yes Home Based Carers, 2 Data typists,
Right-to-Care linkage officer, Right-
to-Care supervisor
5
Cunningmore clinic Public 300 No (Linkage officer
resigned in 2016)
Data typist, 2 staff nurses, Home Based
Carers, Right-to-Care supervisor
3
Justicia clinic Public 423 No Data typist, Home Based Carers, staff
nurse
4
Kildare clinic Public 586 Yes Facility manager, data typist, Right-to-






Public 133 Attached (same
linkage officer
works in Belfast and
Bhubezi)
Data typist, Right-to-Care linkage
officer
3
Xanthia clinic Public 235 Attached (same
linkage officer
works in Agincourt)
Data typist, Home Based Carers, Right-
to-Care linkage officer
3
Box 1. Description of the organisations that assist with tracing in Agincourt.
Right-to-care:
● Founded in 2001
● Non-profit organisation who provide prevention, care and treatment for HIV and associated diseased (tuberculosis, cervical cancer, and other
STIs)
● Work with government and communities to find solutions to build and strengthen public health care
● In Agincourt, this constitutes assistance with tracing usually through assistance with telephone tracing
Home-Based cares:
● Started in the late 1980s in rural villages of the Limpopo region
● Introduced as a way of improving healthcare practices to promote health through population sensitisation around aspects including child care,
nutrition, and personal hygiene
● In recent years they have become more strucutred and are at the forefront of healthcare service delivery including delivery of treatment, care
and support for people living with HIV
● In Agincourt they assist with healthcare promotion and physical tracing of people living with HIV who are late for their scheduled clinic visits
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produce these instruments when requested and we
could not find evidence of any intervention in patient
files, TIER.Net, or any documentation kept by RtC and
HBC and was classified as ‘not done’ where clinic staff
admitted that an intervention was not performed.
Data analysis
Data from the clinic record review was exported to Stata
14 for analysis. We produced a checklist for each clinic
to determine whether each tracing step was optimally
used, inconsistent, not observed or not done. Data were
then summarised using proportions and frequencies.
Results
Expected implementation of the routine tracing
system
In all of the clinics in this study setting LTFU was
defined as being more than 90 days late for a scheduled
appointment in accordance with national policy [30].
All health facilities routinely traced HIV patients who
were LTFU (Figure 1). Each health facility manager is
responsible for ensuring that there is a functioning
paper-based or electronic appointment system such
that clinical files for patients who are expected the
following day are retrieved from the filing room. Files
for patients who do not attend a scheduled visit should
be kept aside for further action. A list of patients who
did not attend a scheduled appointment should be
generated every week, either through the facility’s
appointment register or through querying the facility-
level electronic database (TIER.Net). If a patient has not
attended the facility within five working days to follow-
up on a missed scheduled appointment, the patient’s
name should be registered in the facility tracing register
to be traced.
This list should be signed off by the facility man-
ager and transferred to the person responsible for
tracing patients, usually a designated nurse, commu-
nity health worker (CHW) or the ward-based out-
reach team (WBOT) lead. The delegated nominee
should extract contact information including
addresses and telephone numbers (which should be
updated at every clinic visit) of the individuals on the
list (and their treatment supporter where available)
from the patient files and enter this information into
the facility tracing register. The facility telephone
should then be used to contact all the individuals
who were added to the tracing register that week,
with the date the phone call was attempted and the
outcome of the phone call, and patient outcomes
recorded in the register when obtained. Three calls
should be attempted within 14 days after each
patient’s missed visit. Patients found to be alive, and
who have not transferred to another clinic should be
encouraged to return to treatment. Self-transfers
should be further investigated usually through
a phone call to the facility they have transferred to
(Six facilities receive assistance with telephone tracing
from RtC). The names of patients who cannot be
reached after three attempts by phone should be
transferred to a list of those to be traced through
outreach and home visits. Patient consent for
a home visit should be verified in the patient file
before HBC attempt household visits.
WBOTs, CHWs and HBC linked to the facility
should be involved to physically trace defaulters.
Details of each home visit, including the outcome of
the visit, should be reported to the facility manager.
Each outreach tracing effort should be marked in the
facility tracing register, indicating the date and out-
come of the tracing visit.
Patients who have not reported back to the clinic for
90 days since their last scheduled visit and do not have
a tracing outcome e.g. transferred out, died or stopped
Figure 1. Tracing steps and personnel in charge of each step.
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treatment are then in principle registered as LTFU.
Before this entry is made, one more attempt at phoning
or visiting the patient should be made. Information
from this entire exercise should then be documented
into the patients’ electronic record.
Actual observed performance of the routine
tracing system in the eight health facilities
Overall, none of the eight clinics had optimal per-
formance with regards to any of the indicators
(Figure 2). Optimal use of late patient lists was
observed in 3 (37.5%) clinics, was inconsistent in
3 (37.5%) clinics and was not observed in 2 (25.0%)
clinics. Similarly, tracing registers were inconsis-
tently used in 4 (50.0%) clinics and not observed
in 4 (50.0%) clinics. Phone calls were optimally
used and consistently documented in 2 (25.0%)
clinics, inconsistent in 5 (62.5%) clinics and not
observed in 1 (12.5%) clinic. Finally, physical tra-
cing was optimally used and documented in 1
(12.5%) clinic, inconsistent (usually due to poor
documentation) in 5 (62.5%) clinics, not observed
in 1 (12.5%) clinic, and was not done in 1 (12.5%)
clinic. In both clinics, HBC and other community
health workers were not engaged in the tracing
procedures.
Challenges identified in implementing the routine
tracing system
Through the data collected, conversations with stake-
holders and observations, we identified three major
types of challenges to the optimal implementation of
tracing in the eight facilities: facility-level barriers; chal-
lenges relating to data, documentation and record-
keeping; and challenges relating to the roles of tracing
personnel.
Diversity in clinic procedures
Whilst all the clinics drew guidance on patient tracing
procedures from the same national guidelines and docu-
ments, in practice, their implementation of these guide-
lines varied. For example, each clinic that conducted
routine tracing employed a different filing system and
process for generating patient identification (ID) num-
bers. In some cases, these were based on patient charac-
teristics such as birth dates, whereas in others, they were
generated using sequential numbers. In one clinic, two
different patient ID systems had been implemented, and
while one had been discontinued in favour of another,
both types of patient IDs remained in operation. The way
in which files were stored was also different across the
clinics, with some of them cataloguing and indexing files
while others did not have any discernible filing system.
Tracing procedures were also not consistent between
clinics with different actors involved, and in some cases,
certain tracing steps were not performed.
Furthermore, each clinic used TIER.Net indepen-
dently with no links between the different clinic
databases. This meant that if patients chose to move
between clinics there was no clear way of identifying
them as patients who were already in care elsewhere
and a new file was opened in the receiving clinic.
Moreover, the limited communication between
clinics affected the efficiency and coverage of tracing
activities. For example, if patients resided outside the
catchment area of the HBC organisations attached to
the clinic they were using, they would not be physi-
cally traced, as this would need the involvement of
HBC from another clinic.
Data, documentation and record-keeping
challenges
Weekly lists of patients late for a scheduled clinic visit
were always manually generated from TIER.Net by data
managers. We observed that this was prone to human
Figure 2. Performance on specific indicators from the tracing cascade for eight health facilities.
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error with some patients who should have been cate-
gorised as late for a scheduled appointment being missed
completely and not receiving any tracing interventions.
In five clinics, a total of fifty-three patients who had not
visited the clinic for more than 90 days were recorded as
being still in care and had been missed by the data
manager when the LTFU lists were generated.
Additionally, whilst national tracing guidelines indicate
that every clinic must keep a facility tracing register for
planning, monitoring and research purposes, in most
clinics, these registers could not be found and appeared
not to be part of routine tracing practice. Furthermore,
both TIER.Net and patient files did not have a dedicated
space ormodule for capturing tracing outcomes. In some
clinics, these outcomes were sometimes entered into the
comments section, but this was not consistently done.
Patients in some differentiated care models, including
adherence groups and fast-track treatment collection
appointments visited their clinic less frequently and in
some cases do not have to interact with clinic staff when
they pick up refills. However, TIER.Net and patient files
did not always reflect this information about patients.
This meant that some patients were erroneously cate-
gorised as LTFU, whereas they were still in care through
differentiated care models.
Whilst both RtC and HBC organisations were active
patient tracing partners, they did not always keep records
of their work. In one clinic, an HBC volunteer admitted
that they traced patients, but did not document the tra-
cing, likely due to a myriad of reasons including a lack of
training, a lack of understanding of the importance of
documenting their work, and stationery shortages. Also,
standardised tracing forms were often unavailable, or
unused in practice, and some HBC being apparently
unaware of them. In some clinics, supplies of tracing
forms were expected to be generated by photocopying
an existing form, but the equipment to do this was not
always available or functioning. This led to staff utilising
logbooks or exercise books for record keeping, or in the
worst case, not documenting their work at all.
Impromptu logbooks often had incomplete data and in
some cases, had been lost. HCWs struggled to accurately
and consistently capture quality data as they prioritised
their clinical work.
Additionally, tracing could only be performed if cor-
rect patient telephone numbers and addresses were avail-
able in their file. Also, for some patients the telephone
number used by the clinic was only effective the first time
as once patients recognised the clinic telephone number,
they would not respond to any further calls received
from it.
Challenges relating to roles and responsibilities
of personnel involved in the tracing system
The number of actors involved in routine tracing
varied between clinics, and we observed duplication
of work or transfer of tasks and responsibilities from
one actor to another. For example, as the list of
patients who are LTFU is generated from TIER.Net,
it is the responsibility of the data manager to cross-
check the LTFU list with physical files to confirm that
no patient visit was missed and not entered into the
database. However, in one of the clinics, this duty had
been shifted to the WBOT nurse, meaning she dedi-
cated less time to her clinical work. In some clinics,
the different actors were not aware of each other’s
roles, meaning that work was duplicated, or that in
other cases some patients did not receive all the
tracing interventions because some actors did not
receive their information. In one clinic, the HBC
and RtC personnel had never communicated, culmi-
nating in some patients never being discussed nor
physically traced. Also, whereas tracing organisations
said they informed data managers about tracing done,
this was not always reflected in TIER.Net.
Finally, we heard of various challenges within the
different home-based care organisations. Many of the
HBC felt that they were under-funded, and that because
of this HBC staff worked on a voluntary basis, only
receiving a small stipend from the health department
and some non-monetary incentives. Some expressed
a loss of motivation to do their work which was fostered
by their dissatisfaction with this system. Furthermore,
HBC had not received formal training which could in
some way explain the patients concerns over conduct,
particularly in terms of maintaining confidentiality when
they attempted to trace them. Further issues included
cases whereby the HBC asked family members or friends
of the patient why they had not attended the clinic,
thereby inadvertently disclosing their HIV status.
However, where HBC were active and motivated, they
weremore likely to become aware of a patient missing an
appointment before they were contacted by the clinic. In
one clinic, HBCs routinely visited patients ranking them
by a colour system as stable (green – seen every
1–2 months) or volatile (yellow – seen fortnightly or
red – seen weekly). If they suspected that a patient was
LTFU they then confirmed this at the clinic, later going
back to try to reengage the patient into care. This was
a more practical system, relying less on communication
between actors and less prone to errors due to
miscommunication.
Recommendations for future practice
We found that most clinics had a system in place to
identify and trace patients that had missed
a scheduled clinic appointment. However, in practice,
these procedures were heterogeneous and often led to
gaps, leakages and missed opportunities within the
tracing system. Ultimately this meant that tracing
efforts were inconsistent and probably inefficient.
We identified three main areas of challenges with
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routine tracing activities related to facility-level bar-
riers; data, documentation and record-keeping chal-
lenges; and the roles and responsibilities of the
different actors.
Improved linkages between clinics
Each clinic in Agincourt HDSS has a catchment area
that includes one or more villages within its vicinity.
Home-based carers from the villages in this catch-
ment area are attached to the clinic. However, many
patients choose to initiate treatment at a clinic that
does not correspond to their home village [31–33]. In
such instances, the current tracing strategy is signifi-
cantly constrained due to a lack of linkages between
clinics. Such challenges are further perpetuated by the
way in which clinics are driven to achieve national
targets. National clinic evaluation meetings often pre-
sent clinic targets in a way that fosters competition
amongst clinics, putting unnecessary pressure on
HCW to meet these targets [34]. This competition
might improve some targets (e.g. number of patients
tested or initiated on ART) but undermine the gen-
eral effectiveness of tracing endeavours.
Clinics should be encouraged to coordinate efforts
working together to trace patients. In cases where
a patient is under the jurisdiction of HBC not
attached to a given clinic, there should be procedures
that allow for the clinic to communicate with the
HBCs to facilitate tracing. This would have to be
coupled with significant patient education and sensi-
tisation about the system to make sure they do not
feel that their confidentiality has been breached.
Patients should also be sensitised on the importance
of declaring prior medical history when presenting at
a new facility. Long term, linkages between the dif-
ferent clinic electronic recording systems and better
implementation of unique patient identification
numbers would also help to identify silent transfers.
Enhancements of recording systems
Data quality issues including incompleteness have been
reported as a problem for tracing in other HIV treat-
ment programmes [9]. Studies suggest that data quality
issues can be attributed to limited engagement of
HCWs with the data for their own planning, research,
and monitoring and evaluation purposes [35] as well as
a lack of resources (e.g. logbooks). Insufficient training
of HCWs responsible for recording information and
inadequate auditing procedures to ensure that incom-
plete records are identified and rectified in a timely
manner further exacerbates this issue [35]. Healthcare
workers need to balance different priorities with data
entry often seen as less important.
Large investments have been made in establish-
ing electronic medical records at all the clinics and
each clinic has a dedicated data typist for Tier.Net,
solely responsible for electronic data entry.
However, the system still exists in an ad-hoc fashion
(the data typist copying information from paper
records) and is not fully integrated into medical
practice (i.e. healthcare providers directly entering
information into the system). Efforts are needed to
fully integrate data entry into good clinical practice
and clinic staff should be trained on the importance
of recording all patients’ outcomes. Furthermore,
efforts should be made to motivate HCWs to take
ownership of, and utilise their data for monitoring
and evaluation. Whilst a dedicated module for tra-
cing might be unrealistic in the near future, addi-
tional training on basic data analysis, provision of
mentorship opportunities, as well as training on
auditing records could lead to improvements in
data completeness. Development of standard oper-
ating procedures for data entry and training on
these could further improve data completeness.
Training for lay community healthcare workers
The inadequate healthcare workforce in sub-Saharan
Africa has been well documented [36,37], and task
shifting has been widely recommended and implemen-
ted as an efficient and sustainable strategy to expand
HIV treatment programmes in this setting [38,39].
However, we observed that the voluntary nature of
HBCs, and the non-transparent recruitment strategies
[40] can be problematic. These cadres are expected to
be part of the health system, but not necessarily part of
its organisation. They have shorter training than pro-
fessional healthcare workers, and they require minimal
qualifications [39]. We observed concerns around their
ability to handle confidential information. Over thirty
years ago, Walt [41] identified several challenges to the
success of HBC including lack of remuneration, insuf-
ficient training, poor management, and lack of super-
vision and logistical support which we found to still be
prevalent in this setting.
HBCs should receive specific training in conduct-
ing tracing activities as this has been associated with
sustained motivation, as well as with improving their
ability to respond appropriately to their clients’ needs
[42] and could reduce issues related to breaches of
confidentiality which undermine tracing efforts.
Training could also contribute to furthering the
legitimacy of HBC among patients and formal health
workers [43,44]. Future research should take a more
in-depth consideration of the patient perspective with
regards to routine tracing and its challenges.
Conclusions
Strengthening the recording and routine use of tracing
data will capitalise on this source of information for
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patient monitoring at the facility level and improve the
accuracy of estimates of true outcomes for patients who
become LTFU. This will necessitate significant invest-
ments in the health system, in the training of healthcare
workers, and enhancements in data infrastructure. It is
important that tracing systems and the data they gen-
erate keep abreast with evolving guidelines and rapidly
shifting health service delivery.
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Paper context
Most HIV programmes in sub-Saharan Africa implement
some form of routine tracing for patients who do not
return for scheduled clinic visits. However, this is incon-
sistently done and fraught with issues resulting in many
patients becoming lost to the system. We evaluated routine
tracing in rural South Africa and report on gaps identified
as well as offer recommendations to improve routine tra-
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